Predictive Vulnerability Intelligence.

Product

  • Product
  • Pricing
  • Documentation

Company

  • About
  • Partnerships
  • Blog
  • Support

Legal

  • Terms
  • Privacy
  • Data Licensing

© 2026 FAUCET Technologies LLC. All rights reserved.

CVE-2023-27605

28
FAUCET Score

CVE-2023-27605 is an SQL Injection vulnerability in the WP Reroute Email plugin, affecting versions up to and including 1.4.6. This critical vulnerability (CVSS 9.8) allows unauthenticated attackers to execute arbitrary SQL commands, leading to full compromise of confidentiality, integrity, and availability. While there is no evidence of active exploitation or public exploit code (Metasploit, Nuclei, ExploitDB), the vulnerability has garnered some community discussion and media coverage, indicating awareness.

Impacted Technologies

VendorProductVersion(s)CPE
< 1.4.8CPE matchmatch criteria
cpe:2.3:a:wp_reroute_email_project:wp_reroute_email:*:*:*:*:*:wordpress:*:*

CVSS Data

CVSS version used by this source: 3.1

5.5MEDIUM

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:N/A:L

Attack Vector
NETWORK
Attack Complexity
LOW
Privileges Required
HIGH
User Interaction
NONE
Scope
UNCHANGED
Confidentiality Impact
HIGH
Integrity Impact
NONE
Availability Impact
LOW
Exploitability Score
1.2
Impact Score
4.2
CvssVersion
3.1

Exploit Intelligence

EPSS Score
0.68%
Probability of exploitation in next 30 days
EPSS Percentile
48.7%
Percentile rank of EPSS score among Peer Group
As of 2026-07-27
Model: v2026.06.15
This CVE's current EPSS score of 0.0068 is in the 31st percentile among its peer group of 36,897 CVEs.

Social Chatter

The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.3 Bluesky, 0.3 Mastodon, and 2.4 GitHub mentions.

Media Mentions

The average CVE in this peer group has 0.3 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.

Remediation

Remediation records are not available for this CVE.

References

patchstack.com / database/vulnerability/wp-reroute-email/wordpress-wp-reroute-email-plugin-1-4-6-admin-sql-injection-vulnerability
Third Party Advisory